CSN Login
Members Online: 9

Metastatic TNBC news from San Antonio

AngieD's picture
AngieD
Posts: 504
Joined: Sep 2011

Phase III Study Shows No Overall Benefit for Eribulin over Capecitabine-but TNBC Patients May Have an Advantage

This study compared eribulin to capecitabine in patients with metastatic breast cancer who had already been treated with one or more prior chemotherapy regimens. While overall, the study did not show a benefit for one drug over the other, the subset of triple negative breast cancer patients in the study appeared to do better on the eribulin.

Peter Kauffman, MD, of the Norris Cotton Cancer Center at Dartmouth, said that he thought that the results for TNBC patients were "reasonably encouraging," but noted that there are still many unmet needs for this kind of breast cancer, and that there is a "long way to go."

Angie

Gabe N Abby Mom's picture
Gabe N Abby Mom
Posts: 2415
Joined: Sep 2010

Thanks Angie,

I will certainly look into this...

Hugs,

Linda

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network